PTSM: Pharmaceutical Technology Sourcing and Management, Nov 9, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Nov 9, 2011
Pfizer Outlines Its Supply Strategy
By Patricia Van Arnum
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Global Feature
Contract Manufacturers and Ingredient Suppliers Assemble at CPhI Worldwide.
By Patricia Van Arnum
A roundup of news from fine-chemical suppliers, CDMOs, and CMOs from this year's installment of CPhI Worldwide.
Technical Perspectives from CPhI Worldwide
By Patricia Van Arnum
Pharmaceutical Technology's podcast series from CPhI.
Preparing for the Last War
By Jim Miller
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
CSR and Sustainability Forum
Energy Conservation in Pharmaceutical Manufacturing
By L. Shamkishore , K. Manmadha Reddy , A. Pathy
The authors discuss opportunities for energy efficiency in pharmaceutical manufacturing.
Pharma Companies Focus on Advancing Women
By Patricia Van Arnum
Pharmaceutical companies join international efforts to reduce maternal and child mortality in the developing world.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here